Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
崔伊凡完成签到,获得积分10
刚刚
1秒前
鸡脖肠完成签到,获得积分20
1秒前
乐乐应助福娃娃采纳,获得10
1秒前
苦茶子发布了新的文献求助10
1秒前
2秒前
SLD应助坦率的鸡翅采纳,获得10
2秒前
3秒前
爆米花应助负责的高烽采纳,获得10
3秒前
崔伊凡发布了新的文献求助10
3秒前
4秒前
三模蕾缪安完成签到,获得积分20
4秒前
5秒前
5秒前
22336应助shidewu采纳,获得20
5秒前
yangmingyu完成签到 ,获得积分10
5秒前
152455应助yanglet采纳,获得10
5秒前
杨玉蓉发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
ding应助xxxxx采纳,获得10
8秒前
CipherSage应助zhiyin你太美采纳,获得10
8秒前
8秒前
嘿嘿发布了新的文献求助10
9秒前
9秒前
安详夏旋发布了新的文献求助10
9秒前
10秒前
Komorebi发布了新的文献求助10
10秒前
墨菲应助梅梅也采纳,获得10
10秒前
Orange应助Macgonal采纳,获得10
10秒前
迷路涵菡完成签到,获得积分10
10秒前
Jenna发布了新的文献求助10
10秒前
aa3294完成签到,获得积分20
11秒前
Ye_F完成签到,获得积分10
11秒前
11秒前
希望天下0贩的0应助yuyijk采纳,获得30
12秒前
内科大王完成签到,获得积分10
12秒前
12秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 2500
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
Curating Socialism: A Handbook of International Art Exhibitions 1947-1989 530
Soil mites of the family Rhagidiidae (Actinedida: Eupodoidea). Morphology, Systematics, Ecology 520
A First Course in Options Pricing Theory 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7461323
求助须知:如何正确求助?哪些是违规求助? 9056903
关于积分的说明 19308260
捐赠科研通 7083824
什么是DOI,文献DOI怎么找? 3243970
关于科研通互助平台的介绍 2411664
邀请新用户注册赠送积分活动 2228586